Back
Tarsus Pharmaceuticals Vs. IGC Pharma Industry Stock Comparison
Buy
74
TARS
Tarsus Pharmaceuticals
Last Price:
46.65
Seasonality Move:
21.76%
Sell
32
IGC
IGC Pharma
Last Price:
0.35
Seasonality Move:
-8.68%
Buy
74
Tarsus Pharmaceuticals (TARS)
is a Buy
Is Tarsus Pharmaceuticals a Buy, Sell or Hold?
- The current Tarsus Pharmaceuticals [TARS] share price is $46.50. The Score for TARS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- TARS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
IGC Pharma (IGC)
is a Sell
Is IGC Pharma a Buy, Sell or Hold?
- The current IGC Pharma [IGC] share price is $0.37. The Score for IGC is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- IGC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TARS Stock Price Chart
What is Tarsus Pharmaceuticals's stock price today?
-
The Tarsus Pharmaceuticals share price today is $46.50
The current trend is moderately bullish and TARS is experiencing selling pressure, which indicates risk of future bearish movement.
IGC Stock Price Chart
What is IGC Pharma's stock price today?
-
The IGC Pharma share price today is $0.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IGC is experiencing slight buying pressure.
TARS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.47 | Buy |
| Relative Strength Index (14 RSI): | 65.97 | Buy |
| Chaikin Money Flow: | -608950 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.89 - 46.61) | Buy |
| Bollinger Bands (100): | (24.81 - 38.61) | Buy |
IGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 42 | Sell |
| Chaikin Money Flow: | -78366 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.38 - 0.4) | Sell |
| Bollinger Bands (100): | (0.36 - 0.44) | Sell |
TARS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.25 | Sell |
| 20-day SMA: | 43.2 | Buy |
| 50-day SMA: | 37.01 | Buy |
| 200-day SMA: | 32.59 | Buy |
| 8-day EMA: | 46.84 | Sell |
| 20-day EMA: | 43.74 | Buy |
| 50-day EMA: | 38.46 | Buy |
| 200-day EMA: | 31.4 | Buy |
IGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.38 | Sell |
| 20-day SMA: | 0.39 | Sell |
| 50-day SMA: | 0.37 | Sell |
| 200-day SMA: | 0.41 | Sell |
| 8-day EMA: | 0.38 | Sell |
| 20-day EMA: | 0.38 | Sell |
| 50-day EMA: | 0.38 | Sell |
| 200-day EMA: | 0.4 | Sell |
Tarsus Pharmaceuticals Earnings Growth & TARS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.84 per share, and an increase next year of $0.67 per share.
IGC Pharma Earnings Growth & IGC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.09 per share.
Tarsus Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
IGC Pharma Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||